Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.18
+0.02 (0.20%)
At close: Oct 2, 2026, 4:00 PM EDT
10.20
+0.02 (0.20%)
After-hours: Oct 2, 2026, 7:51 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $778.96 million as of October 2, 2026. Its market cap has increased by 156.14% in one year.
Market Cap
778.96M
Enterprise Value
626.91M
1-Year Change
156.14%
Ranking
Category
Stock Price
$10.18
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $778.96M, an increase of 250.27%. That is a compound annual growth rate of 27.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 778.96M | 151.13% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 809.82M |
| Avalo Therapeutics | 803.91M |
| Immix Biopharma | 802.50M |
| Annexon | 794.34M |
| Attovia Therapeutics | 783.83M |
| Design Therapeutics | 772.26M |
| Geron | 770.97M |
| 4D Molecular Therapeutics | 755.19M |